Abstract
University of California, Davis, Sacramento, California Financial Disclosure Dr. Creinin received a speaking honorarium from Gedeon Richter, Mayne, and Organon. He served on the Advisory Board for Evofem, Fuji Pharma, Gedeon Richter, GlaxoSmithKline, Mayne, Merck, OLIC, Organon, Searchlight, and TherapeuticsMD. He has been a consultant for Danco, Estetra SRL, FHI360, Libbs, Mayne, and Medicines360. The Department of Obstetrics and Gynecology, University of California, Davis, received contraceptive research funding for Dr. Creinin from Chemo Research SL, Evofem, HRA Pharma, Medicines360, Merck, and Sebela.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
